Do you want to read an article? Please log in or register.
The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis
Multiple Sclerosis
Related content
Multiple Sclerosis
Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study
Neurology.
Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A
doi: 10.1212/
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
Multiple Sclerosis
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
Lancet Neurol.
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I
doi: 10.1016/
Multiple Sclerosis
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
Ther Adv Neurol Disord.
Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S
doi: 10.1177/
Multiple Sclerosis
Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis
Mult Scler.
Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R
doi: 10.1177/1352458517722646.
RECOMMENDED
Multiple Sclerosis
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety
★ 2
Recommended by
Prof. Dr Christian Kamm, Faculty Member
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Drug Saf.
Giovannoni G, Galazka A, Schick R, Leist T, Comi G, Montalban X, Damian D, Dangond F, Cook S
doi: 10.1007/s40264-020-00948-x.
Multiple Sclerosis
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue
Mult Scler.
Fitzgerald KC, Morris B, Soroosh A, Balshi A, Maher D, Kaplin A, Nourbakhsh B
doi: 10.1177/1352458520936226.
Aging and Cognitive FunctionsMultiple Sclerosis
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Lancet Neurol.
Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R, Chataway J
doi: 10.1016/S1474-4422
SPECIAL REPORT
Multiple Sclerosis